Autoimmune diseases Co-existing with hepatitis C virus infection

Iranian Journal of Allergy, Asthma and Immunology

Volumn 9, Issue 4, 2010, Pages 191-206

  Jadali, Zohreh ^a   Alavian, Seyed Moayed ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Baqiyatallah Research Center for Gastroenterology and Liver Disease   (Iran)

Author keywords

Autoimmunity; Hepatitis C virus; Immune mediated disease

Indexed keywords

AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTAMATE DECARBOXYLASE ANTIBODY; RIBAVIRIN;

ALOPECIA AREATA; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; BLOOD DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FIBROSING ALVEOLITIS; GLOMERULONEPHRITIS; HEPATITIS C VIRUS; HUMAN; HYPERSPLENISM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; LICHEN PLANUS; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; VASCULITIS; VIRUS INFECTION; VITILIGO;

AUTOIMMUNE DISEASES; ENDOCRINE SYSTEM DISEASES; HEMATOLOGIC DISEASES; HEPACIVIRUS; HEPATITIS C; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KIDNEY DISEASES; NERVOUS SYSTEM DISEASES; RHEUMATIC DISEASES; SKIN DISEASES;

EID: 78650814917     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (179)

1. Bonkovsky HL, Mehta S. Hepatitis C: a review and update. J Am Acad Dermatol. J Am Acad Dermatol 2001; 44(2):159-82.
2. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000; 79(1):47-56.
3. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999; 42(10):2204-12.
4. Kessel A, Elias G, Pavlotzky E, Zuckerman E, Rosner I, Toubi E. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity. Hum Immunol 2007; 68(10):844-8. (Pubitemid 47610698)
5. El-Medany OM, El-Din Abdel Wahab KS, Abu Shady EA, Gad El-Hak N. Chronic liver disease and hepatitis C virus in Egyptian patients. Hepatogastroenterology 1999; 46(27):1895-903. (Pubitemid 29366367)
6. De Vita S, De Re V, Sansonno D, Sorrentino D, Corte RL, Pivetta B, et al. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology 2000; 31(1):182-9.
7. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002; 36(6):1439-45.
8. Crovatto M, Pozzato G, Zorat F, Pussini E, Nascimben F, Baracetti S, et al. Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites of the virus. Haematologica 2000; 85(4):356-61.
9. Ducoulombier D, Roque-Afonso AM, Di Liberto G, Penin F, Kara R, Richard Y, et al. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004; 39(3):817-25. (Pubitemid 38337663)
10. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24(2):135-40.
11. Ramos-Casals M, García-Carrasco M, López-Medrano F, Trejo O, Forns X, López-Guillermo A, et al. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore) 2003; 82(2):87-96.
12. Sansonno D, Iacobelli AR, Cornacchiulo V, Iodice G, Dammacco F. Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin Exp Immunol 1996; 103(3):414-21.
13. Zarebska-Michaluk DA, Lebensztejn DM, Kryczka WM, Skiba E. Extrahepatic manifestations associated with chronic hepatitis C infections in Poland. Adv Med Sci 2010; 55(1):67-73.
14. Hadziyannis SJ. Nonhepatic manifestations and combined diseases in HCV infection. Dig Dis Sci. 1996;41(12 Suppl): 63-74.
15. Aster RH. Pooling of platelets in the spleen: Role in pathogenesis of hypersplenic thrombocytopenia. J Clin Invest 1966; 45(5):645-57.
16. Liebman H. Other immune thrombocytopenias. Semin Hematol 2007; 44(4 Suppl 5):24-34.
17. Liebman HA, Stasi R. Secondary immune thrombocytopenic purpura. Curr Opin Hematol 2007; 14(5):557-73.
18. Zhang L, Li H, Zhao H, Ji L, Yang R. Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center. Eur J Haematol 2003; 70(3):196-7.
19. Rajan SK, Espina BM, Liebman HA. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol 2005; 129(6):818-24.
20. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2002; 97(8):2040-5.
21. Panzer S, Seel E. Is there an increased frequency of autoimmune thrombocytopenia in hepatitis C infection? A review. Wien Med Wochenschr 2003; 153(19-20):417-20.
22. Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006; 12(8):1205-10.
23. Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther 2007; 26(Suppl 1):13-9.
24. Yabu K, Kiyosawa K, Ako S, Usuda S, Yoshizawa K, Tanaka E, et al. Type C chronic hepatitis associated with thrombocytopenia in two patients. J Gastroenterol Hepatol 1994; 9(1):99-104. (Pubitemid 24041956)
25. Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R, Cesaro G, et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol 2001; 113(3):590-5.
26. Hamaia S, Li C, Allain JP. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 2001; 98(8):2293-300.
27. Bordin G, Ballaré M, Zigrossi P, Bertoncelli MC, Paccagnino L, Baroli A, et al. A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion? Clin Exp Rheumatol 1995; 13:39-43.
28. Chiao EY, Engels EA, Kramer JR, Pietz K, Henderson L, Giordano TP, et al. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med 2009; 169(4):357-63.
29. Hyman GA, Southworth H. Hemolytic anemia associated with liver disease. Am J Med Sci 1951; 221(4):448-56.
30. Panush RS, Wilkinson LS, Fagin RR. Chronic active hepatitis associated with eosinophilia and Coombs'-positive hemolytic anemia. Gastroenterology 1973; 64(5):1015-9.
31. Portell A, Pedreira JD, Richart C, Vargas V, Martín C, Guardia J. Autoimmune hemolytic anemia associated with chronic liver disease. Rev Clin Esp 1982; 164(2):101-3.
32. Srinivasan R. Autoimmune hemolytic anemia in treatment-naïve chronic hepatitis C infection. J Clin Gastroenterol 2001; 32(3):245-7.
33. Cauli C, Serra G, Chessa L, Balestrieri C, Scioscia R, Lai ME, et al. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin. Haematologica 2006; 91(6 Suppl):ECR26.
34. Kowdley KV. Hematologic side effects of interferon and ribavirin therapy. J Clin Gastroenterol 2005;39(1 Suppl):3-8
35. Fernández AB. An unusual case of autoimmune hemolytic anemia in treatment naïve hepatitis C virus infection. Hematology 2006; 11(5):385-7.
36. Grimaldi D, Limal N, Noizat-Pirenne F, Janvier D, Godeau B, Michel M. IgA-mediated auto-immune haemolytic anaemia revealing a hepatitis C virus infection. Rev Med Interne 2008; 29(2):135-8.
37. Obermayer-Straub P, Manns MP. Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimmun 2001; 16(3):275-85.
38. Iannuzzella F, Vaglio A, Garini G. Management of hepatitis C virus-related mixed cryoglobulinemia. Am J Med 2010; 123(5):400-8.
39. Lunel F, Musset L. Hepatitis C virus infection and cryoglobulinemia. J Hepatol 1998;29(5):848-55
40. Sansonno D, Lauletta G, Montrone M, Tucci FA, Nisi L, Dammacco F. Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia. Clin Exp Immunol 2006; 143(2):288-96.
41. Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F. Localization of hepatitis virus C antigens in liver and skin tissues of chronic hepatitis C virus infected patients with mixed cryoglobulinemia. Hepatology 1995; 21(2):305-12.
42. Vallat L, Benhamou Y, Gutierrez M, Ghillani P, Hercher C, Thibault V, et al. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum 2004; 50(11):3668-78.
43. Charles ED, Green RM, Marukian S, Talal AH, Lake-Bakaar GV, Jacobson IM, et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood 2008; 111(3):1344-56.
44. Dammacco F, Sansonno D, Piccoli C, Tucci FA, Racanelli V. The cryoglobulins: an overview. Eur J Clin Invest 2001; 31(7):628-38.
45. Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998; 7(4):275-9.
46. Cacoub P, Renou C, Kerr G, Hüe S, Rosenthal E, Cohen P, et al. Influence of HLA DR11 phenotype on the risk of hepatitis C virus associated mixed cryoglobulinemia. Arthritis Rheum 2001; 44(9):2118-24.
47. Gad A, Tanaka E, Matsumoto A, el-Hamid Serwah A, Ali K, Makledy F, et al. Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence. J Med Virol 2003; 70(4):594-9. (Pubitemid 36734724)
48. Ramos-Casals M, Forns X, Brito-Zerón P, Vargas A, Ruiz M, Laguno M, et al. Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection. J Viral Hepat 2007; 14(10):736-42.
49. Sène D, Piette JC, Cacoub P. [Antiphospholipid antibodies, antiphospholipid syndrome and viral infections]. Rev Med Interne 2009;30(2):135-41.
50. Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23(2):199-204.
51. de Larrañaga GF, Harris N, Pierangeli SS, Alonso BS, Schroder T, Fainboim H, et al. Low prevalence of autoimmune antiphospholipid antibodies in hepatic. Medicina (B Aires) 2000;60(6):919-22
52. Ramos-Casals M, Cervera R, Lagrutta M, Medina F, García-Carrasco M, de la Red G, et al. Hispanoamerican Study Group of Autoimmune Manifestations of Chronic Viral Disease (HISPAMEC). Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 2004; 38(7):1009-16.
53. Dalekos GN, Kistis KG, Boumba DS, Voulgari P, Zervou EK, Drosos AA, et al. Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol 2000; 12(1):67-74.
54. Misra R, Venables PJ, Plater-Zyberk C, Watkins PF, Maini RN. Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes. Clin Exp Immunol 1989; 75(1):35-40.
55. Cohen H, Mackie IJ, Anagnostopoulos N, Savage GF, Machin SJ. Lupus anticoagulant, anticardiolipin antibodies, and human immunodeficiency virus in haemophilia. J Clin Pathol 1989; 42(6):629-33.
56. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267(5203):1456-62.
57. Kojima H, Uemura M, Sakurai S, Ann T, Ishii Y, Imazu H, et al. Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance. J Gastroenterol 2002; 37(8):617-25.
58. Ramos-Casals M, Trejo O, García-Carrasco M, Font J. Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 2003; 42(7):818-28.
59. Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 2006; 73(6):633-8.
60. Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol 2000; 12(4):295-9.
61. Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004; 6(2):137-41.
62. Rivera J, García-Monforte A, Pineda A, Millán Núñez-Cortés J. Arthritis in patients with chronic hepatitis C virus infection. J Rheumatol 1999; 26(2):420-4. (Pubitemid 29066749)
63. Hsu FC, Starkebaum G, Boyko EJ, Dominitz JA. Prevalence of rheumatoid arthritis and hepatitis C in those age 60 and older in a US population based study. J Rheumatol 2003; 30(3):455-8.
64. Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis after chronic hepatitis caused by hepatitis C virus infection. Intern Med 1992; 31(4):493-5.
65. Zuckerman E, Keren D, Rozenbaum M, Toubi E, Slobodin G, Tamir A, et al. Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha. Clin Exp Rheumatol 2000; 18(5):579-84.
66. Masuko-Hongo K, Kato T, Nishioka K. Virus-associated arthritis. Best Pract Res Clin Rheumatol 2003; 17(2):309-18.
67. Orge E, Cefle A, Yazici A, Gürel-Polat N, Hulagu S. The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. Rheumatol Int 2010; 30(4):485-8.
68. Ramos-Casals M, Font J, García-Carrasco M, Cervera R, Jiménez S, Trejo O, et al. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 2000; 43(12):2801-6.
69. Perlemuter G, Cacoub P, Sbaï A, Hausfater P, Thibault V, Le TH, et al. Hepatitis C virus infection in systemic lupus erythematosus: a case-control study. J Rheumatol. J Rheumatol 2003; 30(7):1473-8.
70. Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 1999; 31(Suppl 1):39-42.
71. Qin CL, Yang QY, Liao YX. Analysis of clinical and immunological features of patients with systemic lupus erythematosus complicated by hepatitis C virus infection. Di Yi Jun Yi Da Xue Xue Bao 2002; 22(10):939-41.
72. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999; 10(2):413-24.
73. Danesh FR, Lynch P, Kanwar YS. Lupus membranous glomerulonephritis mimicking hepatitis C-associated nephropathy. Am J Kidney Dis 2002; 39(3):19.
74. Albero MD, Rivera F, Merino E, Gil MT, Jimenez LA, Aranda I, et al. Hepatitis C virus infection complicating lupus nephritis. Nephrol Dial Transplant 1996; 11(7):1342-5.
75. Toubi E, Gordon S, Kessel A, Rosner I, Rozenbaum M, Shoenfeld Y, et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 2006; 27(2):134-9.
76. Ramos-Casals M, Loustaud-Ratti V, De Vita S, Zeher M, Bosch JA, Toussirot E, et al. SS-HCV Study Group. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005; 84(2):81-9.
77. García-Carrasco M, Ramos M, Cervera R, Font J, Vidal J, Muñoz FJ, et al. Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997; 56(3):173-5.
78. Coll J, Gambús G, Corominas J, Tomás S, Esteban JI, Guardia J. Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus infection. Ann Rheum Dis 1997; 56(6):390-2.
79. Smyth CM, McKiernan SM, Hagan R, Pilkington R, O'Regan M, Lawlor E, et al. Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1*02. Eur J Gastroenterol Hepatol 2007; 19(6):493-8. (Pubitemid 46725756)
80. Ramos-Casals M, García-Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G, et al. Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001; 80(1):1-8.
81. Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, et al. Serum levels of gamma-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection. Hepatol Res 2003; 25(1):14-21.
82. Toussirot E, Le Huédé G, Mougin C, Balblanc JC, Bettinger D, Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection. J Rheumatol 2002; 29(11):2382-5.
83. Arrieta JJ, Rodríguez-Iñigo E, Ortiz-Movilla N, Bartolomé J, Pardo M, Manzarbeitia F, et al. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001; 158(1):259-64.
84. Mariette X. Sjögren's syndrome and virus. Rev Med Interne 1994; 15(9):601-6.
85. Montaño-Loza AJ, Crispín-Acuña JC, Remes-Troche JM, Uribe M. Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjögren's syndrome. Ann Hepatol 2007; 6(3):150-5.
86. Ramos-Casals M, Sánchez-Tapias JM, Parés A, Forns X, Brito-Zerón P, Nardi N, et al. Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome. J Rheumatol 2006; 33(8):1593-9.
87. Ramos-Casals M, García-Carrasco M, Cervera R, Font J.Sjögren's syndrome and hepatitis C virus. Clin Rheumatol 1999; 18(2):93-100.
88. Curry MP, Golden-Mason L, Nolan N, Parfrey NA, Hegarty JE, O'Farrelly C. Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection. J Hepatol 2000; 32(1):121-5.
89. Coll J, Tomás S, Corominas JM, Gutiérrez J. Sicca syndrome associated with human immunodeficiency virus infection: an immunohistochemical study. Arthritis Rheum 1993; 36(6):875-6.
90. Ramos-Casals M, Garcia-Carrasco M, Cervera R, Font J. Is hepatitis C virus a sialotropic virus? Am J Pathol 2001; 159(4):1593-4.
91. Ali A, Zein NN. Hepatitis C infection: a systemic disease with extrahepatic manifestations. Cleve Clin J Med 2005; 72(11):1005-19.
92. Kamar N, Izopet J, Alric L, Guilbeaud-Frugier C, Rostaing L. Hepatitis C virus-related kidney disease: an overview. Clin Nephrol 2008; 69(3):149-60. (Pubitemid 351351061)
93. Saddadi F, Attari F, Najafi I, Gangi MR, Hakemi M, Amini M. Renal involvement in patients with hepatitis C virus infection. Iran J Kidney Dis 2010; 4(2):123-7.
94. Philipneri M, Bastani B. Kidney disease in patients with chronic hepatitis C. Curr Gastroenterol Rep 2001;3:79-83.
95. Enríquez R, Rodríguez JC, Sirvent AE, Amorós F, Ardoy F, Alvarez M, et al. Prevalence of hepatitis B and C markers in glomerular diseases. Scand J Urol Nephrol 2007; 41(6):535-8.
96. Ayodele OE, Salako BL. Hepatitis C virus (HCV) and chronic renal disease. Afr J Med Med Sci 2003; 32(3):287-91.
97. Pouteil-Noble C, Maiza H, Dijoud F, MacGregor B. Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 2000; 15 (Supl 8):28-33.
98. Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 2005; 140(3):498-506. (Pubitemid 40813960)
99. Garini G, Allegri L, Lannuzzella F, Vaglio A, Buzio C. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies. Acta Biomed 2007; 78(1):51-9.
100. Uchiyama-Tanaka Y, Mori Y, Kishimoto N, Nose A, Kijima Y, Nagata T, et al. Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol 2004; 61(2):144-50.
101. Smith KD, Alpers CE. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens 2005; 14(4):396-403.
102. Carithers RL Jr. Hepatitis C and renal failure. Am J Med 1999; 107(6B):90-94.
103. Fabrizi F, Lunghi G, Andrulli S, Pagliari B, Mangano S, Faranna P, et al. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12(7):1394-8. (Pubitemid 27353029)
104. Bruchfeld A, Lindahl K, Ståhle L, Söderberg M, Schvarcz R. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant 2003; 18(8):1573-80.
105. Heckmann JG, Kayser C, Heuss D, Manger B, Blum HE, Neundörfer B. Neurological manifestations of chronic hepatitis C. J Neurol 1999;246(6):486-91
106. Acharya JN, Pacheco VH. Neurologic complications of hepatitis C. Neurologist 2008; 14(3):151-6.
107. Grewal AK, Lopes MB, Berg CL, Bennett AK, Alves VA, Trugman JM. Recurrent demyelinating myelitis associated with hepatitis C viral infection. J Neurol Sci 2004; 224(1-2):101-6.
108. Morgello S. The nervous system and hepatitis C virus. Semin Liver Dis 2005; 25(1):118-21.
109. Khella SL, Souayah N. Hepatitis C: a review of its neurologic complications. Neurologist 2002; 8(2):101-6.
110. Ghezzi A, Zaffaroni M. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci 2001; 22(Suppl 2):117-22.
111. Morsica G, Bernardi MT, Novati R, Uberti Foppa C, Castagna A, Lazzarin A. Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients. J Med Virol 1997; 53(3):252-4.
112. Maggi F, Giorgi M, Fornai C, Morrica A, Vatteroni ML, Pistello M, et al. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol 1999; 5(3):319-23.
113. Sacconi S, Salviati L, Merelli E. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol 2001; 58(10):1679-81.
114. Kanda T. Chronic hepatitis C infection and peripheral neuropathy; is mixed cryoglobulinemia really important? Intern Med 2003; 42(5):377-8.
115. Lacaille F, Zylberberg H, Hagège H, Roualdès B, Meyrignac C, Chousterman M, et al. Hepatitis C associated with Guillain-Barré syndrome. Liver 1998; 18(1):49-51.
116. Manns MP. Viruses and autoimmune liver disease. Intervirology 1993; 35(1-4):108-15.
117. Pavić S, Simonović J, Boricić I, Svirtlih N. Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C. Srp Arh Celok Lek 2003; 131(11-12):437-42.
118. Storch W. Virus and autoimmunity with emphasis on liver diseases. Immun Infekt 1993; 21(Suppl 1):9-11.
119. Mitchel LS, Jeffers LJ, Reddy KR, Cheinquer H, Coelho-Little E, Moreda R, et al. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III. Am J Gastroenterol 1993; 88(7):1027-34.
120. Vento S, Cainelli F, Renzini C, Concia E.Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance. Lancet 1997; 350(9087):1298-9.
121. Fishman LN, Jonas MM, Lavine JE. Update on viral hepatitis in children. Pediatr Clin North Am 1996; 43(1):57-74.
122. Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, Gasbarrini G. HCV infection and extrahepatic manifestations. Hepatogastroenterology 2003; 50(52):1149-54.
123. Mizukawa Y, Shiohara T. Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: with emphasis on EB virus, human herpesvirus 6 and hepatitis C virus. J Dermatol Sci 2000; 22(3):169-80. (Pubitemid 30068662)
124. Carrozzo M, Gandolfo S, Carbone M, Colombatto P, Broccoletti R, Garzino-Demo P, et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 1996; 25(10):527-33.
125. del Olmo JA, Pascual I, Bagán JV, Serra MA, Escudero A, Rodriguez F, et al. Prevalence of hepatitis C virus in patients with lichen planus of the oral cavity and chronic liver disease. Eur J Oral Sci 2000; 108(5):378-82.
126. Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Demarosi F, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 2004; 151(6):1172-81.
127. Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 2010; 28(1):100-8.
128. Carrozzo M, Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med 2003; 14(2):115-27.
129. Arrieta JJ, Rodriguez-Inigo E, Casqueiro M, Bartolomé J, Manzarbeitia F, Herrero M, et al. Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology 2000; 32(1):97-103.
130. Nagao Y, Sata M, Itoh K, Tanikawa K, Kameyama T.Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 1996; 26(6):495-8.
131. Al Robaee AA, Al Zolibani AA. Oral lichen planus and hepatitis C virus: is there real association? Acta Dermatovenerol Alp Panonica Adriat 2006; 15(1):14-9.
132. Carrozzo M, Quadri R, Latorre P, Pentenero M, Paganin S, Bertolusso G, et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol 2002; 37(3):364-9.
133. Carrozzo M, Pellicano R. Lichen planus and hepatitis C virus infection: an updated critical review. Minerva Gastroenterol Dietol 2008; 54(1):65-74.
134. Pilli M, Penna A, Zerbini A, Vescovi P, Manfredi M, Negro F, et al. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. Hepatology 2002; 36(6):1446-52.
135. Adiloglu AK, Basak PY, Baysal V. Clinical evaluation of vitiligo and its relationship with viral hepatitis. J Eur Acad Dermatol Venereol 2003; 17(3):365-6.
136. Akbayir N, Gökdemir G, Mansur T, Sökmen M, Gündüz S, Alkim C, et al. Is there any relationship between hepatitis C virus and vitiligo? J Clin Gastroenterol 2004; 38(9):815-7.
137. Jadali Z, Eslami MB, Sanati MH, Mansouri P, Mahmoudi M, Maghsoudi N, et al. Hepatitis C virus antibodies and vitiligo disease. Iranian J Publ Health 2005; 34(1):23-6. (Pubitemid 41358359)
138. Ujiie H, Shimizu T, Shimizu H. Generalized pustular psoriasis and Hepatitis C virus infection. Acta Virol 2004; 48(1):63-4.
139. Taglione E, Vatteroni ML, Martini P, Galluzzo E, Lombardini F, Delle Sedie A, et al. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis J Rheumatol 1999; 26(2):370-2.
140. Yamamoto T, Katayama I, Nishioka K. Psoriasis and hepatitis C virus. Acta Derm Venereol 1995; 75(6):482-3.
141. Jadali Z, Mansouri P, Jadali F. There is no relationship between hepatitis C virus and alopecia areata. Eur J Dermatol 2006; 16(1):94-5.
142. Paoletti V, Mammarella A, Basili S, Paradiso M, Di Franco M, De Matteis A, et al. Prevalence and clinical features of skin diseases in chronic HCV infection. A prospective study in 96 patients. Panminerva Med 2002; 44(4):349-52.
143. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996; 25(3):283-91.
144. Testa A, Castaldi P, Fant V, Fiore GF, Grieco V, De Rosa A, et al. Prevalence of HCV antibodies in autoimmune thyroid disease. Eur Rev Med Pharmacol Sci 2006; 10(4):183-6.
145. Ganne-Carrie N, Medini A, Coderc E, Seror O, Christidis C, Grimbert S, et al. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun 2000; 14(2):189-93.
146. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18(2):253-7.
147. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 1998; 158(13):1445-8.
148. Duclos-Vallée JC, Johanet C, Trinchet JC, Deny P, Laurent MF, Duron F, et al. High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis. BMJ 1994; 309(6958):846-7. (Pubitemid 24305009)
149. Metcalfe RA, Ball G, Kudesia G, Weetman AP. Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid 1997; 7(3):421-4.
150. Jadali Z, Esfahanian F, Farhud DD, Alavian SM, Soltan Dallal MM. Hashimoto's thyroiditis and its association with hepatitis C virus infection. Int J Endocrinol Metab 2005; 3(3):116-20.
151. Leri O, Sinopoli MT, Di Prima MA, Paggi A. Hepatitis C virus antibodies and Graves' disease. BMJ 1995; 310:128-9.
152. Jadali Z, Esfahanian F, Eslami MB, Sanati MH. Serum Antibodies against Hepatitis C Virus in Iranian Patients with Graves 'disease. Iran J Allergy Asthma Immunol 2005; 4(2):91-4.
153. Lai ST, Chiu W. Graves'disease in a chronic hepatitis C patient not receiving interferon therapy. Hong Kong Med J 1996; 2(1):104-6.
154. Piszko P, Fleischer K, Simon K, Serafińska S. Endocrine disorders in HCV infection. Przegl Epidemiol 2006; 60(4):707-14.
155. Hsieh MC, Yu ML, Chuang WL, Shin SJ, Dai CY, Chen SC, et al. Virologic factors related to interferon-α-induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol 2000; 142(5):431-7.
156. Quaranta JF, Tran A, Régnier D, Letestu R, Beusnel C, Fuzibet JG, et al. High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies. J Hepatol 1993; 18(1):136-8.
157. Floreani A, Betterle C, Carderi I, Presotto F, Pedini B, Moscon A, et al; Arsita-one Research Group. Is hepatitis C virus a risk factor for thyroid autoimmunity? J Viral Hepat 2006; 13(4):272-7.
158. Everhart J. A confluence of epidemics: does hepatitis C cause type 2 diabetes? Hepatology2001; 33(3):762-3.
159. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in United States. Ann Intern Med 2000; 133(8):592-9.
160. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver disease due to hepatitis C, alcohol or cholestatic disease. J Hepatol 2000; 32(2):209-17.
161. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003; 125(6):1695-704.
162. Hiéronimus S, Fredenrich A, Tran A, Benzaken S, Fénichel P. Antibodies to GAD in chronic hepatitis C patients. Diabetes Care 1997; 20(6):1044.
163. Masuda H, Atsumi T, Fujisaku A, Shimizu C, Yoshioka N, Koike T. Acute onset of type 1 diabetes accompanied by acute hepatitis C: the potential role of proinflammatory cytokine in the pathogenesis of autoimmune diabetes. Diabetes Res Clin Pract 2007; 75(3):357-61.
164. Chen LK, Chou YC, Tsai ST, Hwang SJ, Lee SD. Hepatitis C virus infection-related Type 1 diabetes mellitus. Diabet Med 2005; 22(3):340-3.
165. Bogdanos DP, Rigopoulou EI. Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes. Diabetes Res Clin Pract 2007; 77(1):155-6.
166. Zignego AL, Giannini C, Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 2007; 13(17):2467-78.
167. Lok SS, Egan JJ. Viruses and idiopathic pulmonary fibrosis. Monaldi Arch Chest Dis 2000; 55(2):146-50.
168. Irving WL, Day S, Johnston ID. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis 1993; 148(6 Pt 1):1683-4. (Pubitemid 24002509)
169. Meliconi R, Andreone P, Fasano L, Galli S, Pacilli A, Miniero R, et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic
170. Yamaguchi S, Kubo K, Fujimoto K, Honda T, Sekiguchi M, Sodeyama T. Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha. Thorax 1997; 52(1):33-7.
171. Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, Mihailova AP, Hadjiev EA, Dikova RP, et al. Chronic hepatitis C virus infection: Prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients. World J Gastroenterol 2007; 13(48):6518-28.
172. Ferri C, La Civita L, Fazzi P, Solfanelli S, Lombardini F, Begliomini E, et al. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol 1997; 36(3):360-5.
173. Ferri C, La Civita L, Fazzi P, Solfanelli S, Lombardini F, Begliomini E, et al. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C. Chest 1994; 105(3):939-41.
174. Tsimpoukas F, Goritsas C, Papadopoulos N, Trigidou R, Ferti A. Sarcoidosis in untreated chronic hepatitis C virus infection.Scand J Gastroenterol 2004; 39:401-403.
175. Herrera I, Concha R, Molina EG, Schiff ER, Altman RD. Relapsing polychondritis, chronic hepatitis C virus infection, and mixed cryoglobulemia. Semin Arthritis Rheum 2004; 33(6):388-403.
176. Aslanidis S, Vassiliadis T, Pyrpasopoulou A, Douloumpakas I, Zamboulis C. Inhibition of TNFalpha does not induce viral reactivation in patients with chronic hepatitis C infection: two cases. Clin Rheumatol 2007; 26(2):261-4.
177. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Moorentype hepatitis C virus-associated corneal ulceration. Ophthalmology 1994; 101(4):736-45. (Pubitemid 24113235)
178. Fabbri C, Jaboli MF, Giovanelli S, Azzaroli F, Pezzoli A, Accogli E, et al. Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy. World J Gastroenterol 2003; 9(7):1487-90.
179. Eddy S, Wim R, Peter VE, Tanja R, Jan T, Werner VS. Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection. Dig Dis Sci 1999; 44(1):186-9.